Melatonin improves bowel symptoms in female patients with irritable bowel syndrome: a double‐blind placebo‐controlled study

Summary Background : Melatonin is involved in the regulation of gastrointestinal motility and sensation. Aim : To determine the potential therapeutic effects of melatonin in irritable bowel syndrome (IBS). Method : Seventeen female patients satisfying the Rome II criteria for IBS were randomized to...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Alimentary pharmacology & therapeutics 2005-11, Vol.22 (10), p.927-934
Hauptverfasser:	LU, W. Z., GWEE, K. A., MOOCHHALLA, S., HO, K. Y.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Anxiety - drug therapy Anxiety - etiology Biological and medical sciences Depressive Disorder - drug therapy Depressive Disorder - etiology Digestive system Double-Blind Method Female Gastroenterology. Liver. Pancreas. Abdomen Gastrointestinal Agents - therapeutic use Humans Irritable Bowel Syndrome - complications Irritable Bowel Syndrome - drug therapy Medical sciences Melatonin - therapeutic use Middle Aged Other diseases. Semiology Pharmacology. Drug treatments Sleep Wake Disorders - drug therapy Sleep Wake Disorders - etiology Stomach. Duodenum. Small intestine. Colon. Rectum. Anus Surveys and Questionnaires
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!